AR and metastatic prostate carcinoma: For example, as many as 50% of patients with castrate-resistant metastatic prostate cancer have circulating cancer cells that have substantial amplification of the AR locus, which has been interpreted to predict that, in such patients, androgen signaling continues to play an important growth stimulatory role [45].